hydrocortisone 17-butyrate

Independent reference data for hydrocortisone 17-butyrate (CAS 13609-67-1), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Physicochemical values on record

Documented uses on record

For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.Drugs used to treat or prevent skin disorders or for the routine care of skin.

Synonyms and trade names

hydrocortisone butyrate; Hydrocortisone 17-butyrate; 13609-67-1; Cortisol 17-butyrate; Locoid; Hydrocortisone-17-butyrate; Hydrocortisone-17alpha-butyrate; Locoid Lipocream; 17-O-butyrylcortisol; DTXSID4045896; 05RMF7YPWN; H-17-B; 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate; CHEBI:31674; NSC-758433; 11beta,21-dihydroxy-3,20-dioxopregn-4-en-17-yl butanoate

Regulatory listings held on file

GHS notification summary	16.7% (1 / 6)

GHS hazard classification

GHS notification summary	16.7% (1 / 6)
Reported hazard statements	H302, H312, H332 (16.7%), H315 (33.3%), H319 (33.3%), H341 (16.7%), H361 (16.7%), H373 (16.7%)

This chemical does not meet GHS hazard criteria for 16.7% (1 of 6) of reports.

H302+H312+H332 (16.7%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]

What the public record says

hydrocortisone 17-butyrate · CAS 13609-67-1 · C25H36O6. UNII 05RMF7YPWN. LogP: 3.18.

Source: PubChem / Wikidata; the batch COA governs where values differ.